GLUCOSIDOS CARDIOTONICOS PDF

GLUCOSIDOS CARDIOTONICOS EN LA PRACTICA MEDICA (Reuniones celebradas en colaboracion con las Asociaciones Medicas Suizas de lengua. POR LO QUE ESTOS CUERPOS SON LLAMADOS TAMBIÉN GLUCÓSIDOS CARDIOTÓNICOS O CUERPOS DIGITÁLICOS. LOS CARDIOTÓNICOS SON. PRESENTACION SOBRE INSUFICIENCIA RENAL, FISIOLOGIA PATOLOGIA, ETIOLOGIA, SINTOMATOLOGIA. by lysique.

Author: Arashir Goltigore
Country: Grenada
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 12 February 2012
Pages: 313
PDF File Size: 17.73 Mb
ePub File Size: 10.60 Mb
ISBN: 185-2-90036-556-3
Downloads: 86093
Price: Free* [*Free Regsitration Required]
Uploader: Sharisar

Method of using 3-cyanoarylpyridine derivatives as modulators of androgen receptor function. Process for the preparation of amino acids useful in the preparation of peptide receptor modulators.

Glucosidos cardiotonicos pdf files

Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use.

Procedimiento de obtencion de 1-timoxipropanol-aminas farmacologicamente activos. Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases.

Harakoa Books :: CRASH COURSE CARDIOLOGY

Disubstituierte phenolaether des 3-aminohydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. N- 4-sulfonylaryl cyclylaminehydroxyethylamines as beta-3 adrenergic receptor agonists.

  HANAYAMA QUARTET PUZZLE SOLUTION PDF

Isotopically labeled triazolopyridine beta hydroxysteroid dehydrogenase type I inhibitors. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases. Verfahren zur herstellung angereicherter diastereomeren von propranololanaloga mit zwei chiralen zentren.

N- 4-sulfonylaryl Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists. A1 Designated state s: Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists.

Index of /portal/leamos_ciencia/VOLUMEN_I/ciencia2/51/imgs

Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods. Derives aryloxypropanolamines, leur procede de preparation et leurs applications.

Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions. Ethanamine derivatives, their preparation and use in pharmaceutical compositions.

Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento.

Methyl and cardiotomicos substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV. Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders. Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors. Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV. Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions. US USA en Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein.

  HARI TATYA PDF

Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds. Agonists of guanylate cyclase useful glucoeidos the treatment of gastrointestinal disorders, inflammation, cancer and other disorders.

Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists.

Processes and intermediates for the preparation of 5-[2- 4- benzoisothiazolyl -piperazinyl ethyl]chloro-1,3-dihydro-indolone. Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists.

Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists. Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant.

Kind code of ref document: Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method. Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists. Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them.